World-class Facilities

Catalent’s cell therapy expertise and network spans globally with facilities across the US and Europe. To meet the high standards for our customers, we have built and developed world-class development and manufacturing centers across the globe that are equipped with industry-leading talent, technologies, process efficiencies and regulatory expertise. Additionally, we are well-suited to offer plasmid DNA capabilities at our Maryland and Belgium sites. Our viral vector production sites across Maryland, USA, including an FDA-approved facility, are a testament to the high quality and regulatory standards we implement across our cell and gene therapy network.

Catalent’s cell therapy network of clinical and commercial facilities is located in Europe (Gosselies, Belgium) and the USA (Princeton, New Jersey).

European Center of Excellence

Gosselies, Belgium Clinical Manufacturing Facility

FDA/EMA compliant facility and quality systems
~67,000 sq. ft. of clinical manufacturing space
- 12 CGMP clean rooms with independent HVAC/Agile shutdown
- 4 process development labs
- Flexible manufacturing space
- In-house Quality Control
- Scale-up and scale-out of autologous and allogeneic programs
- Grade B storage
- Nitrogen storage
- Fill/finish services

Gosselies, Belgium Commercial Campus

60,000 sq. ft. of commercial space
Dedicated commercial suites
Next-generation fill/finish platform
QC testing labs

Our newest large-volume commercial production capacity will be located both in Gosselies, Belgium, and is expected to be commissioned soon with state-of-the-art design to meet current quality standards.

Dusseldorf, Germany iPSC Clinical Facility

7,500 sq.ft. of space
GMP certified
iPSC culture, S1 labs & equipment
Cleanrooms, Class A–D
Development labs
QC labs
High-security cryostorage

Princeton, NJ Commercial Manufacturing Facility

FDA/EMA compliant facility
~30,000 sq. ft. of space
- 16 flexible, CGMP clean rooms
- QC labs
- Warehouse
- Supports autologous and allogeneic programs